INC Research Holdings Inc (INCR) Receives Average Rating of “Hold” from Analysts
Shares of INC Research Holdings Inc (NASDAQ:INCR) have earned an average recommendation of “Hold” from the eleven analysts that are presently covering the stock. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and five have given a buy rating to the company. The average 1 year price objective among analysts that have covered the stock in the last year is $55.00.
Several research firms have issued reports on INCR. Zacks Investment Research downgraded INC Research Holdings from a “hold” rating to a “sell” rating in a report on Tuesday. Jefferies Group LLC restated a “buy” rating on shares of INC Research Holdings in a report on Thursday, May 11th. Robert W. Baird upgraded INC Research Holdings from a “neutral” rating to an “outperform” rating and boosted their price objective for the stock from $46.00 to $66.00 in a report on Thursday, May 11th. SunTrust Banks, Inc. downgraded INC Research Holdings from a “buy” rating to a “hold” rating and set a $48.00 price objective on the stock. in a report on Monday, March 20th. Finally, TheStreet downgraded INC Research Holdings from a “b-” rating to a “c” rating in a report on Thursday, March 23rd.
TRADEMARK VIOLATION NOTICE: “INC Research Holdings Inc (INCR) Receives Average Rating of “Hold” from Analysts” was originally reported by American Banking News and is the sole property of of American Banking News. If you are accessing this news story on another website, it was copied illegally and reposted in violation of United States and international trademark & copyright law. The original version of this news story can be read at https://www.americanbankingnews.com/2017/05/19/inc-research-holdings-inc-incr-receives-average-rating-of-hold-from-analysts.html.
Shares of INC Research Holdings (NASDAQ:INCR) traded down 1.06% during midday trading on Friday, hitting $56.00. 888,436 shares of the stock were exchanged. The stock has a market cap of $3.03 billion, a P/E ratio of 26.64 and a beta of 1.74. INC Research Holdings has a one year low of $36.70 and a one year high of $57.25. The stock’s 50-day moving average price is $46.17 and its 200 day moving average price is $48.93.
INC Research Holdings (NASDAQ:INCR) last posted its quarterly earnings data on Wednesday, May 10th. The company reported $0.60 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.55 by $0.05. The firm had revenue of $252.10 million for the quarter, compared to the consensus estimate of $250.76 million. INC Research Holdings had a return on equity of 49.42% and a net margin of 6.58%. The business’s revenue for the quarter was up 1.2% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.58 EPS. On average, analysts anticipate that INC Research Holdings will post $2.68 earnings per share for the current year.
In other news, CAO Christopher L. Gaenzle sold 4,733 shares of the company’s stock in a transaction dated Monday, April 3rd. The stock was sold at an average price of $45.70, for a total value of $216,298.10. Following the transaction, the chief accounting officer now owns 53,050 shares in the company, valued at approximately $2,424,385. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Alistair Macdonald sold 9,467 shares of the company’s stock in a transaction dated Monday, May 1st. The shares were sold at an average price of $45.00, for a total value of $426,015.00. Following the completion of the transaction, the chief executive officer now owns 83,935 shares in the company, valued at approximately $3,777,075. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 23,028 shares of company stock worth $1,039,573. Corporate insiders own 1.70% of the company’s stock.
Institutional investors have recently modified their holdings of the stock. Envestnet Asset Management Inc. acquired a new position in shares of INC Research Holdings during the fourth quarter worth $109,000. Invictus RG acquired a new position in shares of INC Research Holdings during the first quarter worth $115,000. Crow Point Partners LLC acquired a new position in shares of INC Research Holdings during the third quarter worth $116,000. Foresters Investment Management Company Inc. acquired a new position in shares of INC Research Holdings during the first quarter worth $128,000. Finally, Fifth Third Bancorp increased its position in shares of INC Research Holdings by 5.4% in the first quarter. Fifth Third Bancorp now owns 2,904 shares of the company’s stock worth $133,000 after buying an additional 149 shares in the last quarter. Institutional investors own 99.79% of the company’s stock.
INC Research Holdings Company Profile
INC Research Holdings, Inc is a global contract research organization (CRO). The Company focuses on Phase I to Phase IV clinical development services for the biopharmaceutical and medical device industries. The Company operates through two segments: Clinical Development Services and Phase I Services.
Receive News & Ratings for INC Research Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for INC Research Holdings Inc and related companies with MarketBeat.com's FREE daily email newsletter.